Identification of risk factors for toxicity in patients with hormone receptor-positive advanced breast cancer treated with bevacizumab plus letrozole: a CALGB 40503 (alliance) correlative study

Daneng Li, Linda M. McCall, Olwen M. Hahn, Clifford A. Hudis, Harvey J. Cohen, Hyman B. Muss, Aminah Jatoi, Jacqueline M. Lafky, Karla V. Ballman, Eric P. Winer, Debu Tripathy, Bryan Schneider, William Barry, Maura N. Dickler, Arti Hurria

Research output: Contribution to journalArticle

1 Scopus citations

Fingerprint Dive into the research topics of 'Identification of risk factors for toxicity in patients with hormone receptor-positive advanced breast cancer treated with bevacizumab plus letrozole: a CALGB 40503 (alliance) correlative study'. Together they form a unique fingerprint.

Medicine & Life Sciences